Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Two TBE Vaccines in Children
NCT00311441Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2005
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of tick-borne encephalitis vaccine in tick-borne encephalitis (TBE), sponsored by Novartis. Started Mar 2005; status: completed.
02
Drugs
tick-borne encephalitis vaccine
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT00311441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311441.